| 2015 |
Gatea S, Lu B, Ou H, McCartney G. Numerical simulation and experimental investigation of ductile fracture in SPIF using modified GTN model. In: 4th International Conference on New Forming Technology (ICNFT 2015); 2015. MATEC Web of Conferences; vol 21. |
0 |
0 |
| 2015 |
Lu B, Xu DK, Liu RZ, Ou HA, Long H, Chen J. Cranial reconstruction using double side incremental forming. Key Eng Mater. 2015;639:535-542. |
2 |
2 |
| 2005 |
Cirovic S, Bhola RM, Hose DR, Howard IC, Lawford PW, Parsons MA. A computational study of the optic nerve evulsion. In: Gilchrist MD, ed. IUTAM Symposium on Impact Biomechanics: From Fundamental Insights to Applications. Dordrecht, The Netherlands: Springer; 2005:469-476. Solid Mechanics and Its Applications; vol 124. |
0 |
0 |
| 2008 |
Živanović S, Pavić A. Vibration exposure in offices: a case study. In: Proceedings of the 2nd American Conference on Human Vibration. June 4-6, 2008; Chicago, IL.104-105. |
0 |
0 |
| 2019 |
McDermid J, Koopman P, Hierons R, Khastgir S, Clark JA, Fisher M, Alexander R, Eder K, Thomas P, Barrett G, Torr P, Blake A, Ramamoorthy S. Certification of highly automated vehicles for use on public roads. In: Proceedings of the 26th International Technical Conference on the Enhanced Safety of Vehicles (ESV). June 10-13, 2019; Eindhoven, Netherlands. |
0 |
0 |
| 2015 |
Almagirby A, Carré MJ, Rongong JA. A new methodology for measuring vibration transmissibility on a gripped handle for HAVS research. In: Proceedings of the 13th International Conference on Hand-Arm Vibration. October 13-15, 2015; Beijing, China.62-63. |
0 |
0 |
| 2019 |
Khalil HH, Rongong JA, Carré MJ. The effect of grip force on an upper arm under both continuous and shock vibration using the MDOF model. In: 54th UK Conference on Human Response to Vibration. September 24-26, 2019; Edinburgh, UK. |
0 |
0 |
| 2021 |
Martelli S, Giorgi M, Dall'Ara E, Perilli E. Damage tolerance and toughness of elderly human femora. Acta Biomater. March 15, 2021;123:167-177. |
3 |
1 |
| 2019 |
Knowles NK, Kusins J, Faieghi M, Ryan M, Dall’Ara E, Ferreira LM. Material mapping of QCT-derived scapular models: a comparison with micro-CT loaded specimens using digital volume correlation. Ann Biomed Eng. November 2019;47(11):2188-2198. |
5 |
2 |
| 2013 |
Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos. December 2013;8(1):136. |
85 |
63 |
| 2013 |
Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA; EU review panel of the IOF. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. December 2013;8(1):137. |
27 |
19 |
| 2017 |
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, Reid DM, Selby P, Thompson F, Thurston A, Vine N; The National Osteoporosis Guideline Group (NOGG). UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. December 2017;12(1):1-24. |
43 |
26 |
| 2020 |
Chen X, Hughes R, Mullin N, Hawkins RJ, Holen I, Brown NJ, Hobbs JK. Mechanical heterogeneity in the bone microenvironment as characterized by atomic force microscopy. Biophys J. August 4, 2020;119(3):502-513. |
2 |
2 |
| 2009 |
Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX® and its applications to clinical practice. Bone. May 2009;44(5):734-743. |
39 |
33 |
| 2011 |
Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. April 2011;48(4):677-692. |
25 |
24 |
| 2011 |
Russell RGG. Bisphosphonates: the first 40 years. Bone. July 2011;49(1):2-19. |
44 |
42 |
| 2017 |
Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC. Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone. December 2017;105:11-17. |
23 |
22 |
| 2020 |
Simpson EL, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P, Davis S. Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis. Bone. January 2020;130:115081. |
3 |
3 |
| 2020 |
Zarecki P, Hackl M, Grillari J, Debono M, Eastell R. Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures. Bone. January 2020;130:115113. |
7 |
3 |
| 2020 |
Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N, Eastell R. The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: the T-score bone marker approach in the TRIO study. Bone. February 2020;131:115158. |
1 |
0 |
| 2020 |
Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR, Eastell R. The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: a systematic review and meta-analysis. Bone. March 2020;132:115173. |
1 |
0 |
| 2020 |
Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A, Wang A, Pannacciulli N, Cummings SR. Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension. Bone. May 2020;134:115268. |
2 |
0 |
| 2020 |
Fontalis A, Eastell R. The challenge of long-term adherence: the role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis. Bone. July 2020;136:115336. |
0 |
0 |
| 2020 |
Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR, Eastell R. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone. August 2020;137:115457. |
18 |
16 |
| 2020 |
Gossiel F, Eastell R. Response to letter relating to Gossiel F, paggiosi MA, Naylor KE, et al. The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: the T-score bone marker approach in the TRIO study. Bone. August 2020;137:115430. |
0 |
0 |
| 2020 |
Reid IR, Green JR, Lyles KW, Reid DM, Trechsel U, Hosking DJ, Black DM, Cummings SR, Russell RGG, Eriksen EF. Zoledronate. Bone. August 2020;137:115390. |
4 |
3 |
| 2020 |
Cummings SR, Santora AC, Black DM, Russell RGG. History of alendronate. Bone. August 2020;137:115411. |
5 |
4 |
| 2020 |
Wilkinson JM. The use of bisphosphonates to meet orthopaedic challenges. Bone. August 2020;137:115443. |
0 |
0 |
| 2020 |
Heymann M-F, Lezot F, Heymann D. Bisphosphonates in common pediatric and adult bone sarcomas. Bone. October 2020;139:115523. |
0 |
0 |
| 2020 |
Coleman R. Bisphosphonates and breast cancer: from cautious palliation to saving lives. Bone. November 2020;140:115570. |
2 |
2 |
| 2020 |
Schini M, Nicklin P, Eastell R. Establishing race-, gender- and age-specific reference intervals for pyridoxal 5′-phosphate in the NHANES population to better identify adult hypophosphatasia. Bone. December 2020;141:115577. |
2 |
1 |
| 2021 |
Salam S, Gallagher O, Hughes D, Khwaja A, Eastell R. The role of static bone histomorphometry in diagnosing renal osteodystrophy. Bone. January 2021;142:115689. |
0 |
0 |
| 2021 |
Salam S, Gallagher O, Gossiel F, Paggiosi M, Eastell R, Khwaja A. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease. Bone. February 2021;143:115699. |
0 |
0 |
| 2021 |
Winsor C, Li X, Qasim M, Henak CR, Pickhardt PJ, Ploeg H, Viceconti M. Evaluation of patient tissue selection methods for deriving equivalent density calibration for femoral bone quantitative CT analyses. Bone. February 2021;143:115759. |
4 |
3 |
| 2021 |
McCloskey E, Paterson AH, Powles T, Kanis JA. Clodronate. Bone. February 2021;143:115715. |
3 |
2 |
| 2021 |
Desborough R, Nicklin P, Gossiel F, Balasubramanian M, Walsh JS, Petryk A, Teynor M, Eastell R. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone. March 2021;144:115795. |
3 |
3 |
| 2021 |
Talevski J, Sanders KM, Busija L, Beauchamp A, Duque G, Borgström F, Kanis JA, Svedbom A, Stuart AL, Brennan-Olsen S. Health service use pathways associated with recovery of quality of life at 12-months for individual fracture sites: analyses of the International Costs and Utilities Related to Osteoporotic fractures study (ICUROS). Bone. March 2021;144:115805. |
0 |
0 |
| 2021 |
Hoover-Fong J, Cheung MS, Fano V, Hagenas L, Hecht JT, Ireland P, Irving M, Mohnike K, Offiah AC, Okenfuss E, Ozono K, Raggio C, Tofts L, Kelly D, Shediac R, Pan W, Savarirayan R. Lifetime impact of achondroplasia: current evidence and perspectives on the natural history. Bone. May 2021;146:115872. |
2 |
2 |
| 2021 |
Sedghizadeh PP, Sun S, Jones AC, Sodagar E, Cherian P, Chen C, Junka AF, Neighbors JD, McKenna CE, Russell RGG, Ebetino FH. Bisphosphonates in dentistry: historical perspectives, adverse effects, and novel applications. Bone. June 2021;147:115933. |
0 |
0 |
| 2021 |
D'Oronzo S, Wood S, Brown JE. “The use of bisphosphonates to treat skeletal complications in solid tumours”. Bone. June 2021;147:115907. |
0 |
0 |
| 2021 |
Arshad F, Bishop N. Osteogenesis imperfecta in children. Bone. July 2021;148:115914. |
1 |
1 |
| 2021 |
Shalof H, Dimitri P, Shuweihdi F, Offiah AC. Which skeletal imaging modality is best for assessing bone health in children and young adults compared to DXA? a systematic review and meta-analysis. Bone. September 2021;150:116013. |
0 |
0 |
| 2021 |
Palanca M, Barbanti-Bròdano G, Marras D, Marciante M, Serra M, Gasbarrini A, Dall'Ara E, Cristofolini L. Type, size, and position of metastatic lesions explain the deformation of the vertebrae under complex loading conditions. Bone. October 2021;151:116028. |
1 |
0 |
| 2022 |
Wadanamby S, El Garwany S, Connolly DJA, Arundel P, Bishop NJ, DeVile CJ, Calder AD, Crowe B, Burren CP, Saraff V, Offiah AC; Highly Specialised Service for Severe, Complex and Atypical Osteogenesis Imperfecta (NHS England). Monitoring skull base abnormalities in children with osteogenesis imperfecta: review of current practice and a suggested clinical pathway. Bone. January 2022;154:116235. |
0 |
0 |
| 2022 |
Black DM, Condra K, Adams AL, Eastell R. Bisphosphonates and the risk of atypical femur fractures. Bone. March 2022;156:116297. |
0 |
0 |
| 2022 |
Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Dunford JE, Sedghizadeh PP, McKenna CE, Srinivasan V, Boeckman RK, Russell RGG. Bisphosphonates: the role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone. March 2022;156:116289. |
0 |
0 |
| 2022 |
Mattia L, Davis S, Mark-Wagstaff C, Abrahamsen B, Peel N, Eastell R, Schini M. Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation). Bone. May 2022;158:116347. |
1 |
1 |
| 2023 |
Schini M, Bhatia P, Shreef H, Johansson H, Harvey NC, Lorentzon M, Kanis JA, Bandmann O, McCloskey EV. Increased fracture risk in Parkinson's disease: an exploration of mechanisms and consequences for fracture prediction with FRAX. Bone. March 2023;168:116651. |
0 |
0 |
| 2023 |
Kowo-Nyakoko F, Gregson CL, Madanhire T, Stranix-Chibanda L, Rukuni R, Offiah AC, Micklesfield LK, Cooper C, Ferrand RA, Rehman AM, Ward KA. Evaluation of two methods of bone age assessment in peripubertal children in Zimbabwe. Bone. May 2023;170:116725. |
0 |
0 |
| 2023 |
Palanca M, Cavazzoni G, Dall'Ara E. The role of bone metastases on the mechanical competence of human vertebrae. Bone. August 2023;173:116814. |
0 |
0 |
| 2013 |
Zysset PK, Dall'Ara E, Varga P, Pahr DH. Finite element analysis for prediction of bone strength. BoneKEy Rep. August 2013;2:386. |
37 |
28 |
| 2020 |
Marino S, Carrasco G, Li B, Shah KM, Lath DL, Sophocleous A, Lawson MA, Idris AI. JZL184, a monoacylglycerol lipase inhibitor, induces bone loss in a multiple myeloma model of immunocompetent mice. Calcif Tiss Int. July 2020;107(1):72-85. |
0 |
0 |
| 2021 |
Jørgensen HS, David K, Salam S, Evenepoel P; European Renal Osteodystrophy (EUROD) workgroup, an initiative of the CKD-MBD working group of the ERA-EDTA. Traditional and non-traditional risk factors for osteoporosis in CKD. Calcif Tiss Int. April 2021;108(4):496-511. |
2 |
1 |
| 2021 |
Cavalier E, Eastell R, Jørgensen NR, Makris K, Tournis S, Vasikaran S, Kanis JA, Cooper C, Pottel H, Morris HA; IFCC-IOF Committee for Bone Metabolism (C-BM). A multicenter study to evaluate harmonization of assays for -terminal telopeptides of type I collagen (ß-CTX): a report from the IFCC-IOF committee for bone metabolism (C-BM) [published correction appears in Calcif Tiss Int. June 2021;108(6):825-826]. Calcif Tiss Int. June 2021;108(6):785-797. |
0 |
0 |
| 2021 |
Cavalier E, Eastell R, Jørgensen NR, Makris K, Tournis S, Vasikaran S, Kanis JA, Cooper C, Pottel H, Morris HA. Correction to: a multicenter study to evaluate harmonization of assays for C-terminal telopeptides of type I collagen (ß-CTX): a report from the IFCC-IOF committee for bone metabolism (C-BM). Calcif Tiss Int. June 2021;108(6):825-826. |
0 |
0 |
| 2020 |
Pepe V, Oliviero S, Cristofolini L, Dall’Ara E. Regional nanoindentation properties in different locations on the mouse tibia from C57BL/6 and Balb/C female mice. Front Bioeng Biotechnol. May 15, 2020;8:478. |
0 |
0 |
| 2017 |
Dall’Ara E, Peña-Fernández M, Palanca M, Giorgi M, Cristofolini L, Tozzi G. Precision of digital volume correlation approaches for strain analysis in bone imaged with micro-computed tomography at different dimensional levels. Front Mater. November 8, 2017;4:31. |
25 |
11 |
| 2016 |
Lu B, Ou H, Shi SQ, Long H, Chen J. Titanium based cranial reconstruction using incremental sheet forming. Int J Mater Form. July 2016;9(3):361-370. |
0 |
0 |
| 2014 |
Dall’Ara E, Barber D, Viceconti M. About the inevitable compromise between spatial resolution and accuracy of strain measurement for bone tissue: a 3D zero-strain study. J Biomech. September 22, 2014;47(12):2956-2963. |
39 |
21 |
| 2016 |
Modenese L, Ceseracciu E, Reggiani M, Lloyd DG. Estimation of musculotendon parameters for scaled and subject specific musculoskeletal models using an optimization technique. J Biomech. January 25, 2016;49(2):141-148. |
7 |
6 |
| 2016 |
Palanca M, Cristofolini L, Dall’Ara E, Curto M, Innocente F, Danesi V, Tozzi G. Digital volume correlation can be used to estimate local strains in natural and augmented vertebrae: an organ-level study. J Biomech. December 8, 2016;49(16):3882-3890. |
12 |
1 |
| 2017 |
Palanca M, Bodey AJ, Giorgi M, Viceconti M, Lacroix D, Cristofolini L, Dall'Ara E. Local displacement and strain uncertainties in different bone types by digital volume correlation of synchrotron microtomograms. J Biomech. June 14, 2017;58:27-36. |
20 |
11 |
| 2018 |
Modenese L, Montefiori E, Wang A, Wesarg S, Viceconti M, Mazzà C. Investigation of the dependence of joint contact forces on musculotendon parameters using a codified workflow for image-based modelling. J Biomech. May 17, 2018;73:108-118. |
9 |
7 |
| 2019 |
Comini F, Palanca M, Cristofolini L, Dall’Ara E. Uncertainties of synchrotron microCT-based digital volume correlation bone strain measurements under simulated deformation. J Biomech. March 27, 2019;86:232-237. |
9 |
5 |
| 2014 |
Chen Y, Pani M, Taddei F, Mazzà C, Li X, Viceconti M. Large-scale finite element analysis of human cancellous bone tissue micro computer tomography data: a convergence study. J Biomech Eng. October 2014;136(10):101013. |
10 |
6 |
| 2015 |
Palanca M, Tozzi G, Cristofolini L, Viceconti M, Dall'Ara E. Three-dimensional local measurements of bone strain and displacement: comparison of three digital volume correlation approaches. J Biomech Eng. July 2015;137(7):071006. |
30 |
14 |
| 1987 |
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. December 1987;2(6):595-610. |
359 |
326 |
| 1996 |
O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ; The Eutopean Vertebral Osteoporosis Study Group. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis study. J Bone Miner Res. July 1996;11(7):1010-1018. |
35 |
25 |
| 1998 |
Luckman SP, Hughes DE, Coxon FP, Russell RGG, Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res. April 1998;13(4):581-589. |
21 |
18 |
| 2003 |
Eastell R, Barton I, Hannon R, Chines A, Garnero P, Delmas P. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res. June 2003;18(6):1051-1056. |
28 |
23 |
| 2005 |
Delmas PD, van de Langerijt L, Watts NB, Eastell R, Genant H, Grauer A, Cahall DL; IMPACT Study Group. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res. April 2005;20(4):557-563. |
23 |
22 |
| 2010 |
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res. November 2010;25(11):2350-2358. |
23 |
7 |
| 2012 |
Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RLM, Tan M, Ruzycky ME, Su G, Eastell R. The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. February 2012;27(2):243-254. |
24 |
18 |
| 2012 |
Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. February 2012;27(2):301-308. |
27 |
24 |
| 2014 |
Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP. Trabecular bone score: a noninvasive analytical method based upon the dxa image. J Bone Miner Res. March 2014;29(3):518-530. |
38 |
28 |
| 2014 |
Bala Y, Zebaze R, Ghasem-Zadeh A, Atkinson EJ, Iuliano S, Peterson JM, Amin S, Bjørnerem Å, Melton LJ III, Johansson H, Kanis JA, Khosla S, Seeman E. Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res. June 2014;29(6):1356-1362. |
30 |
23 |
| 2014 |
Kanis JA, Svedbom A, Harvey N, McCloskey EV. The osteoporosis treatment gap. J Bone Miner Res. September 2014;29(9):1926-1928. |
10 |
4 |
| 2015 |
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. January 2015;30(1):3-23. |
39 |
23 |
| 2015 |
Evans AL, Paggiosi MA, Eastell R, Walsh JS. Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res. May 2015;30(5):920-928. |
21 |
19 |
| 2018 |
Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen J-EB, McClung M, Roux C, Törring O, Valter I, Wang AT, Brown JP. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. February 2018;33(2):190-198. |
35 |
27 |
| 2019 |
Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML. The efficacy and safety of vertebral augmentation: a second ASBMR task force report. J Bone Miner Res. 2019;34(1):3-21. |
6 |
3 |
| 2019 |
Bouxsein ML, Eastell R, Lui L-Y, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM; FNIH Bone Quality Project. Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res. April 2019;34(4):632-642. |
27 |
22 |
| 2019 |
Bouxsein ML, Eastell R, Liu L, Wu LA, Papp AEd, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM; FNIH Bone Quality Project. Reply to: change in bone density and reduction in fracture risk: a meta‐regression of published trials. J Bone Miner Res. October 2019;34(10):1977-1978. |
1 |
1 |
| 2020 |
Buchbinder R, Ebeling PR, Akesson K, Bauer DC, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML. Response to: some questions about the article “the efficacy and safety of vertebral augmentation: a second ASBMR task force report”. J Bone Miner Res. January 2020;35(1):212-213. |
0 |
0 |
| 2020 |
Duckworth AD, McQueen MM, Tuck CE, Tobias JH, Wilkinson JM, Biant LC, Pulford EC, Aldridge S, Edwards C, Roberts CP, Ramachandran M, McAndrew AR, Cheng KCK, Johnston P, Shah NH, Mathew P, Harvie J, Hanusch BC, Harkess R, Rodriguez A, Murray GD, Ralston SH. Response to: “Effects of alendronic acid on fracture healing”. J Bone Miner Res. January 2020;35(1):215-216. |
0 |
0 |
| 2020 |
Mikolajewicz N, Bishop N, Burghardt AJ, Folkestad L, Hall A, Kozloff KM, Lukey PT, Molloy‐Bland M, Morin SN, Offiah AC, Shapiro J, van Rietbergen B, Wager K, Willie BM, Komarova SV, Glorieux FH. HR‐pQCT measures of bone microarchitecture predict fracture: systematic review and meta‐analysis. J Bone Miner Res. March 2020;35(3):446-459. |
28 |
23 |
| 2020 |
Chotiyarnwong P, McCloskey E, Eastell R, McClung MR, Gielen E, Gostage J, McDermott M, Chines A, Huang S, Cummings SR. A pooled analysis of fall incidence from placebo‐controlled trials of denosumab. J Bone Miner Res. June 2020;35(6):1014-1021. |
1 |
1 |
| 2021 |
Eastell R, Black DM, Lui L, Chines A, Marin F, Khosla S, de Papp AE, Cauley JA, Mitlak B, McCulloch CE, Vittinghoff E, Bauer DC; Foundation for the National Institutes of Health (FNIH) Bone Quality Project. Treatment‐related changes in bone turnover and fracture risk reduction in clinical trials of antiresorptive drugs: proportion of treatment effect explained. J Bone Miner Res. February 2021;36(2):236-243. |
0 |
0 |
| 2021 |
Talevski J, Sanders KM, Busija L, Beauchamp A, Duque G, Borgström F, Kanis JA, Svedbom A, Connaughton C, Stuart AL, Brennan‐Olsen SL. Health service use and quality of life recovery 12 months following major osteoporotic fracture: latent class analyses of the international costs and utilities related to osteoporotic fractures study (icuros). J Bone Miner Res. February 2021;36(2):252-261. |
0 |
0 |
| 2021 |
Fusaro M, Cozzolino M, Plebani M, Iervasi G, Ketteler M, Gallieni M, Aghi A, Locatelli F, Cunningham J, Salam S, Zaninotto M, Ravera M, Russo D, Mereu MC, Giannini S, Brandi ML, Ferrari S, Sella S, Egan CG, Bellasi A, Lullo LD, Tripepi G, Nickolas T. Sevelamer use, vitamin K levels, vascular calcifications, and vertebral fractures in hemodialysis patients: results from the VIKI study. J Bone Miner Res. March 2021;36(3):500-509. |
0 |
0 |
| 2021 |
Harvey NC, Kanis JA, Liu E, Cooper C, Lorentzon M, Bea JW, Carbone L, Cespedes Feliciano EM, Laddu DR, Schnatz PF, Shadyab AH, Stefanick ML, Wactawski‐Wende J, Crandall CJ, Johansson H, McCloskey E. Predictive value of DXA appendicular lean mass for incident fractures, falls, and mortality, independent of prior falls, FRAX, and BMD: findings from the Women's Health Initiative (WHI). J Bone Miner Res. April 2021;36(4):654-661. |
5 |
4 |
| 2021 |
Ramchand SK, David NL, Lee H, Eastell R, Tsai JN, Leder BZ. Efficacy of zoledronic acid in maintaining areal and volumetric bone density after combined denosumab and teriparatide administration: DATA-HD study extension. J Bone Miner Res. May 2021;36(5):921-930. |
1 |
0 |
| 2021 |
Vilaca T, Paggiosi M, Walsh JS, Selvarajah D, Eastell R. The effects of type 1 diabetes and diabetic peripheral neuropathy on the musculoskeletal system: a case–control study. J Bone Miner Res. June 2021;36(6):1048-1059. |
2 |
2 |
| 2021 |
Harvey NC, Orwoll E, Kwok T, Karlsson MK, Rosengren BE, Ribom E, Cauley JA, Cawthon PM, Ensrud K, Liu E, Cruz-Jentoft AJ, Fielding RA, Cooper C, Kanis JA, Lorentzon M, Ohlsson C, Mellström D, Johansson H, McCloskey E. Sarcopenia definitions as predictors of fracture risk independent of FRAX®, falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: a meta-analysis. J Bone Miner Res. July 2021;36(7):1235-1244. |
5 |
4 |
| 2022 |
Eastell R, Vittinghoff E, Lui L-Y, McCulloch CE, Pavo I, Chines A, Khosla S, Cauley JA, Mitlak B, Bauer DC, Bouxsein M, Black DM. Validation of the surrogate threshold effect for change in bone mineral density as a surrogate endpoint for fracture outcomes: the FNIH-ASBMR SABRE project. J Bone Miner Res. January 2022;37(1):29-35. |
5 |
3 |
| 2022 |
Zheng Z, Johansson H, Harvey NC, Lorentzon M, Vandenput L, Liu E, Kanis JA, McCloskey EV. Potential adverse effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on bisphosphonate efficacy: an exploratory post hoc analysis from a randomized controlled trial of clodronate. J Bone Miner Res. June 2022;37(6):1117-1124. |
1 |
1 |
| 2022 |
Vilaca T, Velmurugan N, Smith C, Abrahamsen B, Eastell R. Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports. J Bone Miner Res. June 2022;37(6):1188-1199. |
0 |
0 |
| 2022 |
Farzi M, Pozo JM, McCloskey E, Eastell R, Harvey NC, Frangi AF, Wilkinson JM. Quantitating age-related BMD textural variation from DXA region-free-analysis: a study of hip fracture prediction in three cohorts. J Bone Miner Res. September 2022;37(9):1679-1688. |
1 |
1 |
| 2022 |
Eastell R, Vittinghoff E, Lui L-Y, Ewing SK, Schwartz AV, Bauer DC, Black DM, Bouxsein ML. Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk. J Bone Miner Res. November 2022;37(11):2121-2131. |
0 |
0 |
| 2022 |
Perri G, Hill TR, Mathers JC, Walsh JS, Gossiel F, Winther K, Frölich J, Folkestad L, Cold S, Eastell R. Long-term selenium-yeast supplementation does not affect bone turnover markers: a randomized placebo-controlled trial. J Bone Miner Res. November 2022;37(11):2165-2173. |
0 |
0 |
| 2022 |
Fuleihan GE-H, Chakhtoura M, Cipriani C, Eastell R, Karonova T, Liu J-M, Minisola S, Mithal A, Moreira CA, Peacock M, Schini M, Silva B, Walker M, El Zein O, Marcocci C. Classical and nonclassical manifestations of primary hyperparathyroidism. J Bone Miner Res. November 2022;37(11):2330-2350. |
3 |
2 |
| 2022 |
Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA, Roszko KL, Yao L, Guyatt GH, Thakker RV, Xia W, Brandi M-L. Hypoparathyroidism: genetics and diagnosis. J Bone Miner Res. December 2022;37(12):2615-2629. |
4 |
1 |
| 2023 |
Ye C, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA, Leslie WD. Performance of FRAX in men with prostate cancer: a registry-based cohort study. J Bone Miner Res. May 2023;38(5):659-664. |
0 |
0 |
| 2019 |
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. May 2019;104(5):1595-1622. |
23 |
20 |
| 2017 |
Chen Y, Dall’Ara E, Sales E, Manda K, Wallace R, Pankaj P, Viceconti M. Micro-CT based finite element models of cancellous bone predict accurately displacement once the boundary condition is well replicated: a validation study. J Mech Behav Biomed Mater. January 2017;65:644-651. |
31 |
18 |
| 2017 |
Tozzi G, Dall’Ara E, Palanca M, Curto M, Innocente F, Cristofolini L. Strain uncertainties from two digital volume correlation approaches in prophylactically augmented vertebrae: local analysis on bone and cement-bone microstructures. J Mech Behav Biomed Mater. March 2017;67:117-126. |
15 |
4 |
| 2018 |
Oliviero S, Giorgi M, Dall'Ara E. Validation of finite element models of the mouse tibia using digital volume correlation. J Mech Behav Biomed Mater. October 2018;86:172-184. |
16 |
8 |
| 2019 |
Kusins J, Knowles N, Ryan M, Dall’Ara E, Ferreira L. Performance of QCT-derived scapula finite element models in predicting local displacements using digital volume correlation. J Mech Behav Biomed Mater. September 2019;97:339-345. |
6 |
3 |
| 2022 |
Dall’Ara E, Bodey AJ, Isaksson H, Tozzi G. A practical guide for in situ mechanical testing of musculoskeletal tissues using synchrotron tomography. J Mech Behav Biomed Mater. September 2022;133:105297. |
0 |
0 |
| 2023 |
Mitchell RL, Dunlop T, Volkenandt T, Russell J, Davies P, Spooner S, Pleydell-Pearce C, Johnston R. Methods to expose subsurface objects of interest identified from 3D imaging: the intermediate sample preparation stage in the correlative microscopy workflow. J Microsc (Oxford). February 2023;289(2):107-127. |
0 |
0 |
| 2022 |
Rapagna S, Roberts BC, Solomon LB, Reynolds KJ, Thewlis D, Perilli E. Relationships between tibial articular cartilage, in vivo external joint moments and static alignment in end-stage knee osteoarthritis: a micro-CT study. J Orthop Res. May 2022;40(5):1125-1134. |
0 |
0 |
| 2017 |
Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. November 2017;5(11):908-923. |
16 |
13 |
| 2020 |
Ryan MK, Oliviero S, Costa MC, Wilkinson JM, Dall’Ara E. Heterogeneous strain distribution in the subchondral bone of human osteoarthritic femoral heads, measured with digital volume correlation. Materials. 2020;13(20):4619. |
3 |
2 |
| 2012 |
Estrada K, Styrkarsdottir U, Evangelou E, Hsu Y-H, Duncan EL, Ntzani EE, Oei L, Albagha OME, Amin N, Kemp JP, Koller DL, Li G, Liu C-T, Minster RL, Moayyeri A, Vandenput L, Willner D, Xiao S-M, Yerges-Armstrong LM, Zheng H-F, Alonso N, Eriksson J, Kammerer CM, Kaptoge SK, Leo PJ, Thorleifsson G, Wilson SG, Wilson JF, Aalto V, Alen M, Aragaki AK, Aspelund T, Center JR, Dailiana Z, Duggan DJ, Garcia M, Garcia-Giralt N, Giroux S, Hallmans G, Hocking LJ, Husted LB, Jameson KA, Khusainova R, Kim GS, Kooperberg C, Koromila T, Kruk M, Laaksonen M, Lacroix AZ, Lee SH, Leung PC, Lewis JR, Masi L, Mencej-Bedrac S, Nguyen TV, Nogues X, Patel MS, Prezelj J, Rose LM, Scollen S, Siggeirsdottir K, Smith AV, Svensson O, Trompet S, Trummer O, van Schoor NM, Woo J, Zhu K, Balcells S, Brandi ML, Buckley BM, Cheng S, Christiansen C, Cooper C, Dedoussis G, Ford I, Frost M, Goltzman D, González-Macías J, Kähönen M, Karlsson M, Khusnutdinova E, Koh J-M, Kollia P, Langdahl BL, Leslie WD, Lips P, Ljunggren Ö, Lorenc RS, Marc J, Mellström D, Obermayer-Pietsch B, Olmos JM, Pettersson-Kymmer U, Reid DM, Riancho JA, Ridker PM, Rousseau F, Slagboom PE, Tang NLS, Urreizti R, Van Hul W, Viikari J, Zarrabeitia MT, Aulchenko YS, Castano-Betancourt M, Grundberg E, Herrera L, Ingvarsson T, Johannsdottir H, Kwan T, Li R, Luben R, Medina-Gómez C, Palsson ST, Reppe S, Rotter JI, Sigurdsson G, van Meurs JBJ, Verlaan D, Williams FMK, Wood AR, Zhou Y, Gautvik KM, Pastinen T, Raychaudhuri S, Cauley JA, Chasman DI, Clark GR, Cummings SR, Danoy P, Dennison EM, Eastell R, Eisman JA, Gudnason V, Hofman A, Jackson RD, Jones G, Jukema JW, Khaw K-T, Lehtimäki T, Liu Y, Lorentzon M, McCloskey E, Mitchell BD, Nandakumar K, Nicholson GC, Oostra BA, Peacock M, Pols HAP, Prince RL, Raitakari O, Reid IR, Robbins J, Sambrook PN, Sham PC, Shuldiner AR, Tylavsky FA, van Duijn CM, Wareham NJ, Cupples LA, Econs MJ, Evans DM, Harris TB, Kung AWC, Psaty BM, Reeve J, Spector TD, Streeten EA, Zillikens MC, Thorsteinsdottir U, Ohlsson C, Karasik D, Richards JB, Brown MA, Stefansson K, Uitterlinden AG, Ralston SH, Ioannidis JPA, Kiel DP, Rivadeneira F. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. April 15, 2012;44(5):491-501. |
39 |
18 |
| 2001 |
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Wasnich RD, Greenwald M, Kaufman J-M, Chesnut CH, Reginster J-Y; Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group. NEJM. February 1, 2001;344(5):333-340. |
71 |
54 |
| 2007 |
Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. NEJM. May 3, 2007;356(18):1809-1822. |
90 |
66 |
| 2009 |
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. NEJM. August 20, 2009;361(8):756-765. |
133 |
102 |
| 2000 |
Reginster J-Y, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R; Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int. January 2000;11(1):83-91. |
72 |
61 |
| 2000 |
Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J; Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int. December 2000;11(suppl 6):S2-S17. |
23 |
17 |
| 2011 |
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV. Interpretation and use of FRAX in clinical practice. Osteoporos Int. September 2011;22(9):2395-2411. |
32 |
20 |
| 2017 |
Johansson H, Siggeirsdóttir K, Harvey NC, Odén A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA. Imminent risk of fracture after fracture. Osteoporos Int. March 2017;28(3):775-780. |
34 |
28 |
| 2017 |
Harvey NCW, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster J-Y, Rizzoli R, Cooper C, Kanis JA. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. May 2017;28(5):1507-1529. |
15 |
5 |
| 2018 |
Harvey NC, Odén A, Orwoll E, Lapidus J, Kwok T, Karlsson MK, Rosengren BE, Ribom E, Cooper C, Cawthon PM, Kanis JA, Ohlsson C, Mellström D, Johansson H, McCloskey E. Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) study. J Bone Miner Res. December 2018;33(12):2150-2157. |
17 |
7 |
| 2020 |
Parsons CM, Harvey N, Shepstone L, Kanis JA, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R, Redmond NM, Howe A, Marshall T, Peters TJ, Torgerson D, O’Neill TW, McCloskey E, Cooper C; SCOOP Trial Group. Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial. Osteoporos Int. January 2020;31(1):67-75. |
2 |
1 |
| 2020 |
Vasikaran SD, Bhattoa HP, Eastell R, Heijboer AC, Jørgensen NR, Makris K, Ulmer C, Kanis JA, Cooper C, Silverman S, Cavalier E. Harmonization of commercial assays for PINP: the way forward. Osteoporos Int. March 2020;31(3):409-412. |
2 |
0 |
| 2020 |
Condurache CI, Chiu S, Chotiyarnwong P, Johansson H, Shepstone L, Lenaghan E, Cooper C, Clarke S, Khioe RFS, Fordham R, Gittoes N, Harvey I, Harvey NC, Heawood A, Holland R, Howe A, Kanis JA, Marshall T, O’Neill TW, Peters TJ, Redmond NM, Torgerson D, Turner D, McCloskey E; SCOOP Study Team. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study. Osteoporos Int. March 2020;31(3):457-464. |
0 |
0 |
| 2020 |
Vala CH, Lorentzon M, Sundh V, Johansson H, Lewerin C, Sten S, Karlsson M, Ohlsson C, Johansson B, Kanis JA, Mellström D. Increased risk for hip fracture after death of a spouse: further support for bereavement frailty? Osteoporos Int. March 2020;31(3):485-492. |
0 |
0 |
| 2020 |
Paggiosi MA, Debono M, Walsh JS, Peel NFA, Eastell R. Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study. Osteoporos Int. April 2020;31(4):667-675. |
1 |
1 |
| 2020 |
Vala CH, Kärrholm J, Kanis JA, Johansson H, Sten S, Sundh V, Karlsson M, Lorentzon M, Mellström D. Risk for hip fracture before and after total knee replacement in Sweden. Osteoporos Int. May 2020;31(5):887-895. |
0 |
0 |
| 2020 |
Cummings SR, Eastell R. Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures. Osteoporos Int. June 2020;31(6):1023-1024. |
7 |
5 |
| 2020 |
Leslie WD, Schousboe JT, Morin SN, Martineau P, Lix LM, Johansson H, McCloskey EV, Harvey NC, Kanis JA. Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study. Osteoporos Int. June 2020;31(6):1059-1067. |
9 |
8 |
| 2020 |
Leslie WD, Schousboe JT, Morin SN, Martineau P, Lix LM, Johansson H, McCloskey EV, Harvey NC, Kanis JA. Measured height loss predicts incident clinical fractures independently from FRAX: a registry-based cohort study. Osteoporos Int. June 2020;31(6):1079-1087. |
3 |
2 |
| 2020 |
McCloskey E, Harvey N, Johansson H, Lorentzon M, Vandenput L, Kanis JA. Screening for high fracture risk. Osteoporos Int. June 2020;31(6):1179-1180. |
1 |
1 |
| 2020 |
Bianchi ML, Bishop NJ, Guañabens N, Hofmann C, Jakob F, Roux C, Zillikens MC; Rare Bone Disease Action Group of the European Calcified Tissue Society. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int. August 2020;31(8):1445-1460. |
2 |
1 |
| 2020 |
Söreskog E, Borgström F, Shepstone L, Clarke S, Cooper C, Harvey I, Harvey NC, Howe A, Johansson H, Marshall T, O’Neill TW, Peters TJ, Redmond NM, Turner D, Holland R, McCloskey E, Kanis JA; SCOOP study team. Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporos Int. August 2020;31(8):1499-1506. |
0 |
0 |
| 2020 |
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L, McCloskey EV. Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures. Osteoporos Int. October 2020;31(10):1817-1828. |
8 |
2 |
| 2020 |
Kanis JA, Cooper C, Dawson-Hughes B, Harvey NC, Johansson H, Lorentzon M, McCloskey EV, Reginster J-Y, Rizzoli R; International Osteoporosis Foundation. FRAX and ethnicity. Osteoporos Int. November 2020;31(11):2063-2067. |
0 |
0 |
| 2020 |
Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, Brandi M-L, Cano A, Collins P, Cooper C, Genazzani AR, Hillard T, Kanis JA, Kaufman J-M, Lambrinoudaki I, Laslop A, McCloskey E, Palacios S, Prieto-Alhambra D, Reginster J-Y, Rizzoli R, Rosano G, Trémollieres F, Harvey NC. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? Osteoporos Int. December 2020;31(12):2271-2286. |
1 |
1 |
| 2021 |
McCloskey EV, Harvey NC, Johansson H, Lorentzon M, Vandenput L, Liu E, Kanis JA. Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures. Osteoporos Int. January 2021;32(1):39-46. |
1 |
1 |
| 2021 |
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L, Leslie WD, McCloskey EV. The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture. Osteoporos Int. January 2021;32(1):47-54. |
0 |
0 |
| 2021 |
Larsson BAM, Johansson L, Johansson H, Axelsson KF, Harvey N, Vandenput L, Magnusson P, McCloskey E, Liu E, Kanis JA, Sundh D, Lorentzon M. The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density. Osteoporos Int. January 2021;32(1):75-84. |
4 |
3 |
| 2021 |
Duerksen DR, Lix LM, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Leslie WD. Fracture risk assessment in celiac disease: a registry-based cohort study. Osteoporos Int. January 2021;32(1):93-99. |
1 |
1 |
| 2021 |
Kanis JA, Harvey NC, Lorentzon M, Liu E, Vandenput L, McCloskey EV, Johansson H. Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women. Osteoporos Int. January 2021;32(1):165-171. |
0 |
0 |
| 2021 |
McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, Hadji P, Payer J, Palmer K, Stad R, O’Kelly J, Papapoulos S. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int. February 2021;32(2):251-259. |
3 |
3 |
| 2021 |
Söreskog E, Lindberg I, Kanis JA, Åkesson KE, Willems D, Lorentzon M, Ström O, Berling P, Borgström F. Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden. Osteoporos Int. March 2021;32(3):585-594. |
0 |
0 |
| 2021 |
Cummings SR, Eastell R. Authors’ response to KD Stathopoulos regarding “stop (mis)classifying fractures as high or low trauma or as fragility fractures”. Osteoporos Int. April 2021;32(4):781-781. |
0 |
0 |
| 2021 |
Du J, Hartley C, Brooke-Wavell K, Paggiosi MA, Walsh JS, Li S, Silberschmidt VV. High-impact exercise stimulated localised adaptation of microarchitecture across distal tibia in postmenopausal women. Osteoporos Int. May 2021;32(5):907-919. |
2 |
2 |
| 2017 |
Costa MC, Tozzi G, Cristofolini L, Danesi V, Viceconti M, Dall’Ara E. Micro finite element models of the vertebral body: validation of local displacement predictions. PLoS One. July 11, 2017;12(7):e0180151. |
25 |
15 |
| 2019 |
Oliviero S, Giorgi M, Laud PJ, Dall’Ara E. Effect of repeated in vivo microCT imaging on the properties of the mouse tibia. PLoS One. November 21, 2019;14(11):e0225127. |
2 |
2 |